Speakers from Touchstone Exploration, Shanta Gold, Savannah Resources and Kavango Resources feature in our Natural Resources webinar on May 25th. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,106.00
Bid: 1,098.00
Ask: 1,102.00
Change: 0.00 (0.00%)
Spread: 4.00 (0.36%)
Open: 1,048.00
High: 1,140.00
Low: 1,048.00
Yest. Close: 1,002.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Another Manufacturing Suite At Oxford Biomedica's Oxbox Gets Approval

Tue, 6th Oct 2020 09:44

(Alliance News) - Oxford Biomedica PLC on Tuesday said the fourth GMP manufacturing suite at its new Oxbox manufacturing facility has been approved by a UK regulator.

The gene and cell therapy company said the manufacturing suite, located at its new commercial manufacturing centre in Oxford, was issued a Certificate of GMP compliance by the UK Medicines & Healthcare Products Regulatory Agency.

The first phase of Oxbox consists of six GMP manufacturing suites plus warehousing, support laboratories and cold chain facilities. Construction and commissioning of this phase completed in 2019.

The newly approved fourth suite, along with the previously approved third suite, will be dedicated to manufacturing a Covid-19 viral vector vaccine candidate and equipment for both has been provided by the Vaccine Manufacturing & Innovation Centre.

Chief Executive John Dawson said: "We are delighted that we now have all four GMP suites in Oxbox operational, more than doubling our manufacturing capacity from 2019. I want to personally thank all of those at Oxford Biomedica who have worked tirelessly to bring these suites on-line so quickly to enable the manufacturing at scale of the vaccine candidate. We also want to thank VMIC for their support with the rapid deployment of their equipment to our site, which has played a key part in achieving the operational readiness of these suites in this short timeframe."

Shares in Oxford Biomedica were up 0.7% at 850.79 pence in London on Tuesday morning.

By Anna Farley; annafarley@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News

LONDON MARKET CLOSE: Sterling strengthens after solid UK jobless data

LONDON MARKET CLOSE: Sterling strengthens after solid UK jobless data

18 May 21 17:00

LONDON MARKET MIDDAY: FTSE 100 higher as pound breaks through USD1.42

LONDON MARKET MIDDAY: FTSE 100 higher as pound breaks through USD1.42

18 May 21 12:12

Oxford Biomedica jumps after AstraZeneca orders more Covid-19 vaccines

Oxford Biomedica jumps after AstraZeneca orders more Covid-19 vaccines

18 May 21 11:52

UPDATE 2-FTSE 100 flat as Vodafone loss offsets gains in banks; Oxford Biomedica shines

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Oxford Biomedica rises on robust outlook* Vodafone drops after missing earnings expectations* FTSE 100 up 0.2%, FTSE 250 adds 0.6% (Update...

18 May 21 09:23

LONDON MARKET OPEN: Stocks jump and pound heads towards USD1.42 mark

LONDON MARKET OPEN: Stocks jump and pound heads towards USD1.42 mark

18 May 21 08:45

Oxford Biomedica ups revenue forecast as AstraZeneca lifts vaccine output

(Sharecast News) - Gene and cell therapy group Oxford Biomedica on Tuesday doubled annual earnings guidance after pharmaceutical giant AstraZeneca ordered more Covid-19 vaccines.

18 May 21 08:13

LONDON MARKET PRE-OPEN: Phoenix Group confirms talks for European sale

LONDON MARKET PRE-OPEN: Phoenix Group confirms talks for European sale

18 May 21 07:47

UPDATE 2-EU demands immediate access to UK-made vaccines in AstraZeneca legal battle

* EU demands faster deliveries in first hearing of legal case* AstraZeneca says lower supplies not in breach of contract* EU, UK vie for doses, Astra has under-delivered to both* Next hearings on May 26, EU seeks verdict before end of June (recast...

28 Apr 21 09:23

BROKER RATINGS: RBC upgrades WH Smith and downgrades Dixons Carphone

BROKER RATINGS: RBC upgrades WH Smith and downgrades Dixons Carphone

16 Apr 21 09:49

Oxford Biomedica swings to EBITDA profit

(Sharecast News) - Oxford Biomedica reported a 37% improvement in total revenues in its preliminary results on Thursday, to £87.7m.

15 Apr 21 09:02

Oxford BioMedica annual revenue leaps on AstraZeneca vaccine deal

Oxford BioMedica annual revenue leaps on AstraZeneca vaccine deal

15 Apr 21 09:00

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

8 Apr 21 16:05

Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim

Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim

6 Apr 21 08:19

Oxford Biomedica strikes three-year deal with Boehringer Ingelheim

(Sharecast News) - Gene and cell therapy company Oxford Biomedica has signed a new three-year development and supply agreement with Boehringer Ingelheim, it announced on Tuesday, for the manufacture and supply of various types of viral vectors.

6 Apr 21 08:08

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders

6 Apr 21 07:53

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.